As of Jan 13
| +0.40 / +0.74%|
The 14 analysts offering 12-month price forecasts for Metlife have a median target of 58.50, with a high estimate of 67.00 and a low estimate of 50.00. The median estimate represents a +7.71% increase from the last price of 54.31.
The current consensus among 19 polled investment analysts is to Buy stock in Metlife. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.